DUBLIN, Ohio, Aug. 7, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that Dean Scarborough, former Chairman and Chief Executive Officer of Avery Dennison Corporation, and John Weiland, former Vice Chairman, President and Chief Operating Officer of C.R. Bard, Inc., will join its Board of Directors effective

DUBLIN, Aug. 7, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products™", today announced that Jeffrey C. Smith, Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP, who has been a director since 2017, has re

LOUISVILLE, Ky., Aug. 7, 2019 /PRNewswire/ -- Galen College of Nursing announced today the construction of a new Louisville Campus at Terra Crossing Boulevard, off the Old Henry exit at the Gene Snyder Freeway. The new campus, which will house both the Louisville Campus and the College's national administrative headquarters, will be complete winter of 2020.

HOLLISTON, Mass., Aug. 7, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it will report its financial results for the three and six months ended June 30, 2019 in a press re

INCLINE VILLAGE, Nev., Aug. 7, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and six months ended June 30, 2019:Second Quarter and Recent Financial HighlightsGenerally Accepted Accounting Principles ("GAAP") net loss attributable

JERSEY CITY, N.J., Aug. 7, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today reported financial results for the quarter ended June 30, 2019, and provided an update on recent clinical developments."We

SUNRISE, Fla., Aug. 7, 2019 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced earnings for the second quarter that ended June 30, 2019. U.S. Stem Cell, Inc posted second-quarter earnings of

SAN CARLOS, Calif., Aug. 7, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ:  NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financi

SOUTH SAN FRANCISCO, Calif., Aug. 7, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today reported financial results for the three months ended June 30, 2019, and provided a corporate update.

ROCKVILLE, Md., Aug. 7, 2019 /PRNewswire/ --Reports further positive interim update from RGX-314 Phase I/IIa trial for Wet AMD Well-tolerated at all doses Dose-dependent protein expression levels observed across all five dose cohorts 50% of subjects treated in Cohort 3 remain fre